Business
Taimei Technology and C&R Research Announce Strategic Partnership to Build AI-Powered Clinical Trial Innovation
Taimei Technology (HK.02576), a leading AI-powered drug clinical development platform company, and C&R Research (A359090), a top-tier CRO in South Korea, signed an enterprise-level strategic partnership agreement, officially launching the development of an AI-based clinical trial operations system.
About this update from C&r Research Inc.
[{"type":"text","content":"SEOUL, South Korea and SHANGHAI, May 7, 2026 /PRNewswire/ -- Taimei Technology (HK.02576), a leading AI-powered drug clinical development platform company, and C&R Research (A359090), a top-tier CRO in South Korea, signed an enterprise-level strategic partnership agreement, officially launching the development of an AI-based clinical trial operations system.","length":369,"tagName":"p"},{"type":"image","alt":"Scene from the signing of the strategic cooperation agreement.","displaySize":"","headline":null,"caption":"Scene from the signing of the strategic cooperation agreement.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":243,"url":"https://media.zenfs.com/en/prnewswire.com/2858840beef42b065146392481bbdb77"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Zq3HV.o4VJdOQOVxQmmfdg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQyOA--/https://media.zenfs.com/en/prnewswire.com/2858840beef42b065146392481bbdb77","width":400,"height":243},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/V1NgQItIVK8PY4NlXo2BSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTM4OQ--/https://media.zenfs.com/en/prnewswire.com/2858840beef42b065146392481bbdb77","width":400,"height":243}},"href":"https://mma.prnewswire.com/media/2970069/image1.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Under this partnership, C&R Research will deploy Taimei Technology's leading digital infrastructure and AI Agents across multiple clinical trials to automate and enhance trial design and operational workflows. A particular focus will be on data management, where the EDC + iDM Agent combination will be actively adopted. Innovations such as intelligent data capture and governance, AI-driven eCRF generation, and automated test case creation are expected to boost productivity and quality in clinical research.","length":518,"tagName":"p"},{"type":"text","content":"Leveraging its full-stack AI capabilities, 13 years of industry expertise, and global operational experience, Taimei Technology has deeply focused on the clinical research vertical, and has been among the first to build a comprehensive AI Agent matrix, enabling scenario-based AI applications across the entire clinical research workflow. Key offerings include eCollect (EDC), eBalance (RTSM), eCOA, eCooperate (CTMS), and eArchives (eTMF), iDM Agent, iCTA Agen...